Corcept Therapeutics Incorporated logo CORT - Corcept Therapeutics Incorporated

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 14
HOLD 10
SELL 2
STRONG
SELL 0
| PRICE TARGET: $83.00 DETAILS
HIGH: $135.00
LOW: $30.00
MEDIAN: $91.50
CONSENSUS: $83.00
UPSIDE: 3.87%

Profitability Ratios

Ratio Value
GP Margin 98.3%
EBIT Margin 8.7%
EBITDA Margin 9.0%
Operating Margin 5.9%
Pretax Margin 8.7%
Cont. Ops Margin 13.1%
Net Margin 13.1%
Bottom Line Margin 12.9%

Liquidity Ratios

Ratio Value
Current Ratio 2.92
Quick Ratio 2.85
Solvency Ratio 0.538
Cash Ratio 0.73

Valuation Ratios

Ratio Value
Price/Earnings
36.63
Hist. avg: 33.3
Peers avg: 23.4
PEG Ratio -1.24
Forward PEG -1.24
Price/Book 5.58
Price/Sales 4.75
Price/FCF 25.49
Price/Op Cash Flow 25.45

Debt Ratios

Ratio Value
Debt/Assets 0.0073
Debt/Equity 0.0094
Debt/Capital 0.0093
Long-Term Debt/Capital 0.0077
Financial Leverage 1.29

Cash Flow Ratios

Ratio Value
Working Capital Turnover 2.34
Operating Cash Flow Ratio 0.855
Operating Cash Flow/Sales 18.6%
Free Cash Flow/Operating Cash Flow 99.9%

Coverage Ratios

Ratio Value
Debt Service Coverage 0.00
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage 23.25
Capital Expenditure Coverage 672.97
Dividend + Capital Expenditure Coverage 672.97

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 7.33
EPS 0.959
Debt/Share 0.0588
Cash/Share 3.58
Book Value/Share 6.24
Tangible BV/Share 6.24
Equity/Share 6.24
Operating Cash Flow/Share 1.367
Capital Expenditure/Share 0.002
FCF/Share 1.365

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.499
Earnings Before Tax/EBIT 1.484
Price/Fair Value 5.58
Debt/Market Cap 0.0014
Effective Tax Rate -49.9%
Enterprise Value Multiple 51.20